---
figid: PMC4168072__WJG-20-12381-g002
figtitle: 'Smad3 phospho-isoform signaling: Tumor suppressive TBRI/pSmad3C pathway
  vs carcinogenic JNK/pSmad3L pathway'
organisms:
- Homo sapiens
- NA
organisms_ner:
- Homo sapiens
pmcid: PMC4168072
filename: WJG-20-12381-g002.jpg
figlink: /pmc/articles/PMC4168072/figure/F2/
number: F2
caption: 'Smad3 phospho-isoform signaling: Tumor suppressive TβRI/pSmad3C pathway
  vs carcinogenic JNK/pSmad3L pathway. A: In normal hepatocytes, transforming growth
  factor (TGF)-β activates the TGF-β type I receptor (TβRI), leading to the direct
  phosphorylation of the C-terminal region of Smad3. The C-terminal phosphorylated
  Smad3 (pSmad3C) moves to the nucleus and transmits cytostatic signals by up-regulating
  p21WAF1. The TβRI/pSmad3C pathway is crucial for homeostasis and is a tumor suppressor;
  B: In hepatocytes affected by mitogenic stimuli, pro-inflammatory cytokines activate
  c-Jun N-terminal kinase (JNK), drastically altering the Smad3 signaling to induce
  the phosphorylation of Smad3 at its linker region. The linker-phosphorylated Smad3
  (pSmad3L) undergoes translocation to the nucleus to stimulate c-Myc transcription,
  resulting in a proliferative state. During hepatitis C virus-related chronic liver
  disease progression, the JNK/pSmad3L pathway is constitutively activated and promotes
  carcinogenesis.'
papertitle: Smad3 phospho-isoform signaling in hepatitis C virus-related chronic liver
  diseases.
reftext: Takashi Yamaguchi, et al. World J Gastroenterol. 2014 Sep 21;20(35):12381-12390.
year: '2014'
doi: .na.character
journal_title: .na.character
journal_nlm_ta: .na.character
publisher_name: .na.character
keywords: .na.character
automl_pathway: 0.9081662
figid_alias: PMC4168072__F2
figtype: Figure
redirect_from: /figures/PMC4168072__F2
ndex: ''
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC4168072__WJG-20-12381-g002.html
  '@type': Dataset
  description: 'Smad3 phospho-isoform signaling: Tumor suppressive TβRI/pSmad3C pathway
    vs carcinogenic JNK/pSmad3L pathway. A: In normal hepatocytes, transforming growth
    factor (TGF)-β activates the TGF-β type I receptor (TβRI), leading to the direct
    phosphorylation of the C-terminal region of Smad3. The C-terminal phosphorylated
    Smad3 (pSmad3C) moves to the nucleus and transmits cytostatic signals by up-regulating
    p21WAF1. The TβRI/pSmad3C pathway is crucial for homeostasis and is a tumor suppressor;
    B: In hepatocytes affected by mitogenic stimuli, pro-inflammatory cytokines activate
    c-Jun N-terminal kinase (JNK), drastically altering the Smad3 signaling to induce
    the phosphorylation of Smad3 at its linker region. The linker-phosphorylated Smad3
    (pSmad3L) undergoes translocation to the nucleus to stimulate c-Myc transcription,
    resulting in a proliferative state. During hepatitis C virus-related chronic liver
    disease progression, the JNK/pSmad3L pathway is constitutively activated and promotes
    carcinogenesis.'
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - TGFBR1
  - MAPK8
  - MAPK9
  - MAPK10
  - SMAD3
  - CDKN1A
  - TCEAL1
  - NSG1
  - H3P16
  - MYC
---
